Skip to main content

Steven Petrou, PhD

Professor, Director at Florey Institute for Neuroscience and Mental Health

Location: Melbourne VIC Australia

Steven Petrou is internationally recognized in the field of functional genetics and genomics of neurological disease – especially epilepsy. He was the first to identify a number of disease-causing gene variants and characterize how they cause the associated clinical conditions. He has a long history of industry engagement and development of new therapeutics based on disease models, is an inventor on numerous patents – including eight covering antisense oligonucleotide IP – and has founded two biotech companies to develop precision medicines. One of his lead programs – developed in collaboration with Ionis Pharmaceuticals, the world leader in ASO technology and development – is anticipated to nominate its lead ASO candidate within six months, in preparation of first-in-patient trials in 2021. He is Director of the Florey Institute of Neuroscience and Mental Health, one of the largest neuroscience research institutes in the world.

Associated Grants

  • Brain-penetrating Antisense Oligonucleotide to Down-regulate Alpha-synuclein


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.